Alcohol dehydrogenase, iron containing, 1 promoter hypermethylation associated with colorectal cancer differentiation

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Tae, Chung Hyun ^a   Ryu, Kyung Ju ^b   Kim, Seok Hyung ^a   Kim, Hee Cheol ^a   Chun, Ho Kyung ^a   Min, Byung Hoon ^a   Chang, Dong Kyung ^a   Rhee, Poong Lyul ^a   Kim, Jae J ^a   Rhee, Jong Chul ^a   Kim, Young Ho ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

ADHFE1; Colorectal cancer; Differentiation; Promoter methylation

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ALCOHOL DEHYDROGENASE; ALKALINE PHOSPHATASE; BISULFITE; CARCINOEMBRYONIC ANTIGEN; DLD 1 PROTEIN; DNA; MESSENGER RNA; TRANSCRIPTION FACTOR CDX2; UNCLASSIFIED DRUG;

ADENOMA; ADHFE1 GENE; ADULT; ADVANCED CANCER; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; CRYPT CELL; DNA METHYLATION; DOWN REGULATION; EMBRYO; EPITHELIUM CELL; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC TRANSFECTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; WESTERN BLOTTING;

ADENOMA; ADULT; AGED; ALCOHOL OXIDOREDUCTASES; ANIMALS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DNA METHYLATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MICE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; NEOPLASM GRADING; PROMOTER REGIONS, GENETIC; PROTEIN TRANSPORT; TRANSFECTION;

EID: 84875195795     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-142     Document Type: Article

References (18)

1. Tischoff I, Tannapfel A. Epigenetic alterations in colorectal carcinomas and precancerous lesions. Z Gastroenterol 2008, 46(10):1202-1206. Epub 2008 Oct 1220.
2. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003, 349(21):2042-2054.
3. Zhang W, Glockner SC, Guo M, Machida EO, Wang DH, Easwaran H, Van Neste L, Herman JG, Schuebel KE, Watkins DN. Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer. Cancer Res 2008, 68(8):2764-2772.
4. Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD, Pretlow TP, Yang B, Akiyama Y, Van Engeland M. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 2004, 36(4):417-422. Epub 2004 Mar 2014.
5. Akiyama Y, Watkins N, Suzuki H, Jair KW, van Engeland M, Esteller M, Sakai H, Ren CY, Yuasa Y, Herman JG. GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer. Mol Cell Biol 2003, 23(23):8429-8439.
6. Glockner SC, Dhir M, Yi JM, McGarvey KE, Van Neste L, Louwagie J, Chan TA, Kleeberger W, de Bruine AP, Smits KM. Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res 2009, 69(11):4691-4699. Epub 2009 May 4612.
7. Lind GE, Thorstensen L, Lovig T, Meling GI, Hamelin R, Rognum TO, Esteller M, Lothe RA. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol Cancer 2004, 3:28.
8. Kohonen-Corish MR, Sigglekow ND, Susanto J, Chapuis PH, Bokey EL, Dent OF, Chan C, Lin BP, Seng TJ, Laird PW. Promoter methylation of the mutated in colorectal cancer gene is a frequent early event in colorectal cancer. Oncogene 2007, 26(30):4435-4441. Epub 2007 Jan 4429.
9. Deng Y, Wang Z, Gu S, Ji C, Ying K, Xie Y, Mao Y. Cloning and characterization of a novel human alcohol dehydrogenase gene (ADHFe1). DNA Seq 2002, 13(5):301-306.
10. Kim JY, Tillison KS, Zhou S, Lee JH, Smas CM. Differentiation-dependent expression of Adhfe1 in adipogenesis. Arch Biochem Biophys 2007, 464(1):100-111. Epub 2007 May 2007.
11. Lyon RC, Johnston SM, Panopoulos A, Alzeer S, McGarvie G, Ellis EM. Enzymes involved in the metabolism of gamma-hydroxybutyrate in SH-SY5Y cells: identification of an iron-dependent alcohol dehydrogenase ADHFe1. Chem Biol Interact 2009, 178(1-3):283-287. Epub 2008 Nov 2001.
12. Kim YH, Lee HC, Kim SY, Yeom YI, Ryu KJ, Min BH, Kim DH, Son HJ, Rhee PL, Kim JJ. Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations. Ann Surg Oncol 2011, 18(8):2338-2347.
13. Oster B, Thorsen K, Lamy P, Wojdacz TK, Hansen LL, Birkenkamp-Demtroder K, Sorensen KD, Laurberg S, Orntoft TF, Andersen CL. Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas. Int J Cancerdoi 2011, 129(12):2855-2866. Epub 22011 Apr 25951.
14. Mossman D, Kim KT, Scott RJ. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists. BMC Cancer 2010, 10:366.
15. Guadagni F, Witt PL, Robbins PF, Schlom J, Greiner JW. Regulation of carcinoembryonic antigen expression in different human colorectal tumor cells by interferon-gamma. Cancer Res 1990, 50(19):6248-6255.
16. Sakuma K, Aoki M, Kannagi R. Transcription factors c-Myc and CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing EGF/bFGF-induced epithelial-mesenchymal transition. Proc Natl Acad Sci USA 2012, 109(20):7776-7781. Epub 2012 Apr 7730.
17. Gibson P, Rosella O, Young G. Serum free medium increases expression of markers of differentiation in human colonic crypt cells. Gut 1994, 35(6):791-797.
18. Hinoi T, Loda M, Fearon ER. Silencing of CDX2 expression in colon cancer via a dominant repression pathway. J Biol Chem 2003, 278(45):44608-44616.